Toward molecular imaging using spectral photon-counting computed tomography?

Molecular imaging is a valuable tool in drug discovery and development, early screening and diagnosis of diseases, and therapy assessment among others. Although many different imaging modalities are in use today, molecular imaging with computed tomography (CT) is still challenging owing to its low s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sawall, Stefan (VerfasserIn) , Amato, Carlo (VerfasserIn) , Klein, Laura (VerfasserIn) , Wehrse, Eckhard (VerfasserIn) , Maier, Joscha (VerfasserIn) , Kachelrieß, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2021
In: Current opinion in chemical biology
Year: 2021, Jahrgang: 63, Pages: 163-170
ISSN:1879-0402
DOI:10.1016/j.cbpa.2021.04.002
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cbpa.2021.04.002
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S136759312100048X
Volltext
Verfasserangaben:Stefan Sawall, Carlo Amato, Laura Klein, Eckhard Wehrse, Joscha Maier and Marc Kachelrieß
Beschreibung
Zusammenfassung:Molecular imaging is a valuable tool in drug discovery and development, early screening and diagnosis of diseases, and therapy assessment among others. Although many different imaging modalities are in use today, molecular imaging with computed tomography (CT) is still challenging owing to its low sensitivity and soft tissue contrast compared with other modalities. Recent technical advances, particularly the introduction of spectral photon-counting detectors, might allow overcoming these challenges. Herein, the fundamentals and recent advances in CT relevant to molecular imaging are reviewed and potential future preclinical and clinical applications are highlighted. The review concludes with a discussion of potential future advancements of CT for molecular imaging.
Beschreibung:Gesehen am 06.10.2021
Beschreibung:Online Resource
ISSN:1879-0402
DOI:10.1016/j.cbpa.2021.04.002